Recent research led by doctors at Children's Mercy Hospital has revealed serious respiratory risks associated with the acne drug Bactrim. This groundbreaking study prompted the FDA to update Bactrim's label to include respiratory failure as a potential side effect, influencing acne treatment protocols.
